Psoriatic Arthritis Clinical Trials

18 studies are recruiting for psoriatic arthritis in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies now recruiting

1. A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

   Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Up0122 105, Santa Monica, California

   Locations

   14 in total

   Run by

   UCB Biopharma SRL

   See if you can join NCT06888193 on ClinicalTrials.gov

2. A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

   Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA who have not previously been treated with biologic disease-modif…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   AARR- Chandler AZ, Chandler, Arizona

   Locations

   188 in total

   Run by

   Takeda

   See if you can join NCT06671483 on ClinicalTrials.gov

3. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

   This phase Ib trial studies the side effects of nivolumab and to see how well it works alone and in combination with other treatments, such as ipilimumab, cabozantinib, platinum containing therapy, and fluoropyrimidine, in treating patients with autoimmune disorders and cancer that has spread from …

   Stage

   Phase 1

   Ages

   18 and older

   Site

   University of California Davis Comprehensive Cancer Center, Sacramento, California

   Locations

   52 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT03816345 on ClinicalTrials.gov

4. Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)

   Researchers are looking for new ways to treat Psoriatic Arthritis (PsA). This study will help find out if a study medicine called tulisokibart (MK-7240) can treat symptoms of active PsA. This study assesses the efficacy, safety, and tolerability of tulisokibart in adult participants with active PsA…

   Stage

   Phase 2

   Ages

   18 to 80

   Site

   Arizona Arthritis & Rheumatology Associates, P.C. ( Site 5117), Sun City, Arizona

   Locations

   50 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT07486960 on ClinicalTrials.gov

5. A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

   Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO). The main aim of the study is to know how well zasocitinib (TAK-279) works in participants with active PsA based on their previous experience with specific treatments. The…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ, Mesa, Arizona

   Locations

   123 in total

   Run by

   Takeda

   See if you can join NCT06671496 on ClinicalTrials.gov

6. Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

   Psoriatic arthritis (PsA) is a long-term inflammatory disease that affects the joints and skin. The purpose of this study is to check how safe zasocitinib is, how well it is tolerated and how well it works in adults with PsA over a longer period of time. Adults who completed the 1-year (52-week) tr…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Jeffrey Loomer, MD Arizona Arthritis & Rheumatology Research, Tucson, Arizona

   Locations

   78 in total

   Run by

   Takeda

   See if you can join NCT07286058 on ClinicalTrials.gov

7. A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

   The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with active PsA and obesity or overweight with at least 1 weight-related comorbidity. The study will last up to 12 months.

   Stage

   Phase 4

   Ages

   18 and older

   Site

   AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Avondale, Avondale, Arizona

   Locations

   55 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT06864026 on ClinicalTrials.gov

8. Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders

   The goal of this project is to critically evaluate the effectiveness of an online health program designed to improve diet and self-care in patients with rheumatological conditions, including rheumatoid arthritis (RA), Sjogren's syndrome (SS), systemic lupus erythematosus (SLE), mixed connective tis…

   Stage

   Not phased

   Ages

   18 to 100

   Site

   Univeristy of Iowa, Iowa City, Iowa

   Run by

   Terry L. Wahls

   See if you can join NCT07180537 on ClinicalTrials.gov

9. A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

   To demonstrate that bimekizumab administered intravenously is noninferior to subcutaneous administration.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Pa0019 114, Peoria, Arizona

   Locations

   63 in total

   Run by

   UCB Biopharma SRL

   See if you can join NCT07290036 on ClinicalTrials.gov

10. Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy

    While many studies examine Nonalcoholic fatty liver disease (NAFLD), little is known about its progression to high-risk nonalcoholic steatohepatitis (NASH) in PsA patients. Shared disease mechanisms may explain the increased severity in PsA. This study involves two visits from PsA patients with NAF…

    Stage

    Not phased

    Ages

    Any age

    Site

    University of California, San Diego, San Diego, California

    Run by

    University of California, San Diego

    See if you can join NCT06586281 on ClinicalTrials.gov

11. Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

    This study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who receive or will receive immune checkpoint inhibitor drugs. Patients will be asked their opinions about the design, accessibility, and content of …

    Stage

    Not phased

    Ages

    18 and older

    Site

    M D Anderson Cancer Center, Houston, Texas

    Run by

    M.D. Anderson Cancer Center

    See if you can join NCT04751396 on ClinicalTrials.gov

12. A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis

    A Randomized, Placebo-controlled, Multicenter, Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients with Active Psoriatic Arthritis (UP-SPOUT)

    Stage

    Phase 4

    Ages

    18 and older

    Site

    University Hospitals Cleveland Medical Center, Cleveland, Ohio

    Locations

    5 in total

    Run by

    CARE ARTHRITIS LTD.

    See if you can join NCT06454188 on ClinicalTrials.gov

13. Rheumatology Patient Registry and Biorepository

    To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

    Stage

    Not phased

    Ages

    18 to 99

    Site

    Yale New Haven Hospital, New Haven, Connecticut

    Run by

    Yale University

    See if you can join NCT04402086 on ClinicalTrials.gov

14. Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis

    Psoriatic arthritis (PsA) is a type of arthritis that happens when the body's immune system attacks healthy cells and tissues causing joint pain, stiffness, and swelling. Symptoms can get worse and go away for periods of time. This study will evaluate the efficacy and safety of targeted therapies t…

    Stage

    Phase 2

    Ages

    18 and older

    Site

    Newport Huntington Medical Group /ID# 272764, Huntington Beach, California

    Locations

    37 in total

    Run by

    AbbVie

    See if you can join NCT06865105 on ClinicalTrials.gov

15. Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

    The trial is an open-label randomized study that will examine whether switching to a selective IL23 inhibitor (guselkumab) is more effective than switching to a second TNFi (golimumab) among patients with PsA who have an inadequate response to a TNFi.

    Stage

    Phase 3

    Ages

    18 to 80

    Site

    Family Arthritis Center, Loxahatchee Groves, Florida

    Locations

    14 in total

    Run by

    University of Pennsylvania

    See if you can join NCT05669833 on ClinicalTrials.gov

16. Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

    The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic effect of these medications and to follow live born infants for one year after birth. With respect to fetal outcome, it…

    Stage

    Not phased

    Ages

    Any age

    Site

    University of California, San Diego, La Jolla, California

    Run by

    University of California, San Diego

    See if you can join NCT02103361 on ClinicalTrials.gov

17. Rheumatology Diet Study

    This study aims to collect information on rheumatology patients' dietary habits, autoimmune disease activity, dietary changes, disease symptom improvements, and perceptions on their dietary habits and how it affects their autoimmune disease. The main objective is to see if rheumatology patients cha…

    Stage

    Not phased

    Ages

    18 to 65

    Site

    UCF Health Clinics, Orlando, Florida

    Run by

    University of Central Florida

    See if you can join NCT06339957 on ClinicalTrials.gov

18. Stronger Together Psoriatic Arthritis Wellness Study

    Patients diagnosed with psoriatic arthritis (PsA) confront decisions about how to treat their disease, interact with their health care providers, and modify lifestyle choices that may improve treatment outcomes. With sponsorship support from Janssen and in partnership with the Cleveland Clinic, thi…

    Stage

    Not phased

    Ages

    19 and older

    Site

    Global Healthy Living Foundation, Upper Nyack, New York

    Run by

    Global Healthy Living Foundation

    See if you can join NCT05652608 on ClinicalTrials.gov